Biology Reference
In-Depth Information
Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G,
Haromy A, Korbutt G, Archer SL (2005) Vascular endothelial growth factor gene
therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in
hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
Circulation 112(16):2477-2486
Thelitz S, Oishi P, Sanchez LS, Bekker JM, Ovadia B, Johengen MJ, Black SM, Fineman JR
(2004) Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance
following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 5(3):234-239
Thusu KG, Morin FC 3rd, Russell JA, Steinhorn RH (1995) The cGMP phosphodiesterase
inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 152(5 Pt 1):
1605-1610
Tiktinsky MH, Morin FC 3rd (1993) Increasing oxygen tension dilates fetal pulmonary circulation
via endothelium-derived relaxing factor. Am J Physiol 265(1 Pt 2):H376-H380
Tzao C, Nickerson PA, Russell JA, Gugino SF, Steinhorn RH (2001) Pulmonary hypertension
alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from
fetal lambs. Pediatr Pulmonol 31(2):97-105
Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG
(1995) Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress.
Am J Physiol 269:C1371-C1378
Vento M, Asensi M, Sastre J, Garcia-Sala F, Pallardo FV, Vina J (2001) Resuscitation with room
air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates.
Pediatrics 107(4):642-647
Villanueva ME, Zaher FM, Svinarich DM, Konduri GG (1998) Decreased gene expression of
endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr
Res 44:338-343
Vukcevic Z, Coppola CP, Hults C, Gosche JR (2005) Nitrovasodilator responses in pulmonary
arterioles from rats with nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg 40(11):
1706-1711
Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A (2006)
Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 117(3 Pt 2):
S52-S56
Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll
BJ, Lemons JA, Papile L, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA
(2000) Persistent pulmonary hypertension of the newborn in the era before nitric oxide:
practice variation and outcomes. Pediatrics 105:14-20
Wild LM, Nickerson PA, Morin FC 3rd (1989) Ligating the ductus arteriosus before birth
remodels the pulmonary vasculature of the lamb. Pediatr Res 25:251-257
Worwag S, Mulla H, Luyt D, Firmin RK (2000) Dipyridamole in the treatment of a neonate with
persistent pulmonary hypertension. J R Soc Med 93(2):77-78
Woyda K, Koebrich S, Reiss I, Rudloff S, Pullamsetti SS, Ruhlmann A, Weissmann N, Ghofrani
HA, Gunther A, Seeger W, Grimminger F, Morty RE, Schermuly RT (2009) Inhibition of
phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia.
Eur Respir J 33(4):861-870
Zaccolo M, MovsesianMA (2007) cAMP and cGMP signaling cross-talk: role of phosphodiesterases
and implications for cardiac pathophysiology. Circ Res 100(11):1569-1578
